Birge Berns MD, MRCP, FFPM

Dr. Berns is a physician with 20 years of experience in early and late-stage drug development including strategic, regulatory, and operational aspects, therapeutic area focuses on rheumatology, oncology, and anti-infectives within Janssen/Centocor, Eisai, and Aventis. Currently, she is leading multiple global regulatory biologic teams within the Janssen Immunology group, integrating inputs from regional and functional Regulatory Team members to create a coherent and unified global regulatory strategy across our Immunology portfolio. In her role, she is responsible for negotiations with Health Authorities around the world. She received her medical qualification from the University of Erlangen Nuernberg, Germany where she also received her MD in Forensic Immunology. She gained her clinical experience in the UK NHS. She obtained her MRCP(UK) and Fellowship of the Faculty of Pharmaceutical Medicine in the UK.